Carl-Johan Dalsgaard
Chief Executive Officer chez BioFactor Therapeutics AB
Fortune : 656 225 $ au 31/03/2024
Provenance du réseau au premier degré de Carl-Johan Dalsgaard
Entité | Type d'entité | Industrie | |
---|---|---|---|
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland.
21
| Subsidiary | Investment Managers | 21 |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
Public Company | Pharmaceuticals: Major | 13 | |
CePeP AB
CePeP AB Miscellaneous Commercial ServicesCommercial Services CePeP AB provides pharmaceutical research and development services. Its cell penetrating peptides are used for treatment of cancer and endocrine disorders. The company was founded in November 2001 and is headquartered in Stockholm, Sweden.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
BioCrine AB
5
| Subsidiary | 5 | |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Healthcap IV GP AB
Healthcap IV GP AB Financial ConglomeratesFinance Part of Odlander, Fredrikson & Co. AB, Healthcap IV GP AB is a Swedish company that provides investment services. The private company is based in Sundsvall, Sweden.
1
| Subsidiary | Financial Conglomerates | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Carl-Johan Dalsgaard via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
EUROCINE VACCINES AB | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Founder Chief Executive Officer Chairman | |
NICOX SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Chairman Director/Board Member Director/Board Member | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Chairman Director/Board Member Director/Board Member | |
BIOTAGE AB | Medical Specialties | Director/Board Member Founder Chief Executive Officer Director/Board Member | |
Odlander, Fredrikson & Co. AB
Odlander, Fredrikson & Co. AB Financial ConglomeratesFinance Odlander Fredrikson & Co. AB provides financial support services. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder Chairman | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Director/Board Member Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology BioStratum, Inc. develops and distributes pharmaceutical products. Its products are used for treatment of diabetes and diabetic complications. The firm also develops anti-tumor, cancer, diabetic kidney disease and diabetic eye disease drugs. The company was founded by Karl Tryggvason and J. Wesley Fox in 1994 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
OREXO AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Chairman Chairman Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
A+ Science Holding AB
A+ Science Holding AB MiscellaneousMiscellaneous A+ Science Holding AB operates as an investment company, which operates in the field of medical and biotechnology sector. It invests in the life science sector and especially in human medicine. The company was founded in 1997 and is headquartered in Göteborg, Sweden. | Miscellaneous | Director/Board Member Chief Investment Officer Chief Executive Officer | |
ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Undergraduate Degree Graduate Degree | |
University of Uppsala | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Masters Business Admin Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member | |
University of Stockholm | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
University of Lund | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
Altimmune UK Ltd.
Altimmune UK Ltd. BiotechnologyHealth Technology Altimmune UK Ltd. engages in the discovery and development of prophylactic and therapeutic vaccines against mutating viruses and cancer. It provides T-cell vaccines to protect patients against infectious diseases (most notably mutating viruses) and to treat cancers; and Flunisyn, a DepoVaccine to protect against influenza. The company was founded by Bertrand Georges in 2003 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
University of Gothenburg | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
BONESUPPORT HOLDING AB | Medical Specialties | Chairman Director/Board Member Corporate Officer/Principal | |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member Chairman | |
LTB4 Sweden AB
LTB4 Sweden AB BiotechnologyHealth Technology LTB4 Sweden AB engages in research and product development related to antimicrobial and anti-inflammatory substances through its subsidiaries. The company was founded by Bengt Ingemar Samuelsson on February 26, 2004 and is headquartered in Stockholm, Sweden. | Biotechnology | Founder Director/Board Member Chairman | |
Karolinska Institutet Innovations AB
Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Director/Board Member Chairman Director/Board Member | |
Healthcap 1999 GP AB
Healthcap 1999 GP AB Investment Banks/BrokersFinance Part of Odlander, Fredrikson & Co. AB, Healthcap 1999 GP AB is a private company that manages and trades securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | President Director/Board Member Director/Board Member Director/Board Member | |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Chairman | |
EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member General Counsel | |
NVC Holding AB
NVC Holding AB Investment Banks/BrokersFinance NVC Holding AB owns and manages shares in companies and real property. The company is headquartered in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member Chief Executive Officer Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Executive Officer Director/Board Member Director/Board Member | |
MENDUS AB | Biotechnology | Director of Finance/CFO Director/Board Member Director/Board Member | |
WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
HealthCap Advisor AB
HealthCap Advisor AB Investment ManagersFinance HealthCap Advisor AB provides investment advice. The private company is based in Stockholm, Sweden. | Investment Managers | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Ancilla AB
Ancilla AB Real Estate DevelopmentFinance Ancilla AB manages real properties. The company is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member Director/Board Member Director/Board Member | |
Glionova AB
Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Healthcap Aero Holdings Gp | Director/Board Member Director/Board Member Director/Board Member | ||
Healthcap Orx Holdings Gp AB
Healthcap Orx Holdings Gp AB Investment Banks/BrokersFinance Healthcap Orx Holdings Gp AB is a private company that manages securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Chairman Director/Board Member Director/Board Member Director/Board Member | |
Healthcap Annex Fund I-Ii Bis Gp AB
Healthcap Annex Fund I-Ii Bis Gp AB Financial ConglomeratesFinance Healthcap Annex Fund I-Ii Bis Gp AB operates as an investment holding Swedish company. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Chairman Director/Board Member Director/Board Member | |
Doctrin AB
Doctrin AB Internet Software/ServicesTechnology Services Doctrin AB offers consultancy services within healthcare sector. It offers digital solutions that enable healthcare providers to prioritize, treat, and follow-up with their patients. The company was founded by Per Eriksson, Ashkan Labaf, Magnus Liungman, and Carslo Lorente in 2016 and is headquartered in Stockholm, Sweden. | Internet Software/Services | Corporate Officer/Principal Director/Board Member Director/Board Member | |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Director/Board Member | |
Tribune Therapeutics AB
Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman Chief Executive Officer | |
Nordic Vision Clinics AS
Nordic Vision Clinics AS Hospital/Nursing ManagementHealth Services Part of NVC Holding AB, Nordic Vision Clinics AS is a Norwegian company that provides laser eye surgery. The private company is based in Oslo, Norway. | Hospital/Nursing Management | Director/Board Member Chief Executive Officer Director/Board Member |
Statistiques
Internationale
Suède | 44 |
Royaume-Uni | 3 |
France | 3 |
Danemark | 2 |
Etats-Unis | 2 |
Sectorielle
Health Technology | 26 |
Finance | 11 |
Consumer Services | 7 |
Commercial Services | 5 |
Miscellaneous | 2 |
Opérationnelle
Director/Board Member | 506 |
Chairman | 149 |
Corporate Officer/Principal | 98 |
Independent Dir/Board Member | 77 |
Chief Executive Officer | 57 |
Relations les plus connectées
- Bourse
- Insiders
- Carl-Johan Dalsgaard
- Connexions Sociétés